INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2005

Green tea extract demonstrated no objective responses in advanced lung cancer patients.

A phase I dose-escalation trial evaluated oral green tea extract in 17 patients with advanced lung cancer. The maximum tolerated dose was established at 3 g/m2 per day, with dose-limiting toxicities including nausea, diarrhea, and hypertension. No objective tumor responses occurred, though seven participants maintained stable disease for 4 to 16 weeks before progressing.

Study type
Phase I clinical trial
Who was studied
17 patients with advanced lung cancer
What was measured
Maximum tolerated dose, toxicity, and objective tumor response

THE PAPER

Phase I study of green tea extract in patients with advanced lung cancer.

Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK. Cancer Chemother Pharmacol, 2005.

PubMed 15309507 ↗DOI 10.1007/s00280-004-0859-1 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.